Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order
A successful multi-site ring trial and early access program demonstrate the reproducibility, scalability, and biological insight of the Metabolon Verus™ Metabolomics Profiling Kit across laboratories worldwide MORRISVILLE, N.C., Sept. 8, 2026...
Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea
BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global...
/C O R R E C T I O N -- Kuder, Inc./
In the news release, Kuder Launches New Career Planning Course to Complement MySkillsFuture Assessments in Singapore, issued 19-Aug-2026 by Kuder, Inc. over PR Newswire, we are advised by the company that edits have been made to the original...
King Resources Global, Inc. (OTCQB: KRFG) Subsidiary Heavenly Grace Limited Acquires 23 Collectible Items Valued at $68.9 Million
HONG KONG, Sept. 5, 2026 /PRNewswire/ -- King Resources Global, Inc. (OTCQB: KRFG) ("KRFG" or the "Company") is pleased to announce that its wholly owned subsidiary, Heavenly Grace Limited ("HGL"), has entered into a purchase agreement with...
Fly-E Group, Inc. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-Q
NEW YORK, Sept. 4, 2026 /PRNewswire/ -- Fly-E Group, Inc. (NASDAQ: FLYE, the "Company"), an electric vehicle company engaged in designing, installing, selling and renting smart electric motorcycles, electric bikes, and electric scooters, announced...
FutureCeuticals , Inc. (FC) and Aura Scientific Resolve Coffee Fruit Patent Dispute, Recognize FC Patent Rights, and Initiate Seamless Transition to CognatiQ®
MOMENCE, Ill., Sept. 3, 2026 /PRNewswire/ -- FutureCeuticals, Inc. (FC) and Aura Scientific (Aura) are pleased to announce the resolution of FutureCeuticals' patent and trademark suit related to Aura's NeuroRush® ingredient and FutureCeuticals'...
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
PROVIDENCE, R.I., Sept. 3, 2026 /PRNewswire/ -- EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™, its proprietary in silico platform for assessing the immunogenicity risk of biotherapeutics. The release introduces...
Newmark Closes Acquisition of Altus Group's Development Advisory Business
NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or the "Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations and other owners and...
Formosa Pharmaceuticals Files Clinical Trial Application for TSY-110, an Antibody-Drug Conjugate Biosimilar Targeting HER2-Positive Breast Cancers
TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla® (ado-trastuzumab emtansine) in major regulated markets. TAIPEI, Aug. 28, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWSE: 6838), today announced the...
Joget Introduces Agent Lab, a Program Helping Businesses Build AI Agents Without Code
New community initiative invites businesses to submit real workflow challenges for a free, expert-built AI agent, with selected builds shown live in an exclusive webinar. COLUMBIA, Md., Aug. 27, 2026 /PRNewswire/ -- Joget, Inc., the global innovator...